Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease

Study Status: Not yet Recruiting

A thorough discussion of treatment options to manage inflammatory bowel disease (IBD), including the risks and benefits of each class of medication, can be a complex discussion and time consuming. Having to use a translator adds an additional layer of time and complexity to these discussions as well as potential misunderstanding. Further, in addition to language, cultural differences can also play into treatment acceptance. This study aims to determine the impact of primary language on the selection of treatment for IBD and on disease outcomes.

Sex: ALL
Minimum Age: 18 Years

Researchers look for people who fit a certain description, called eligibility criteria. Below are the inclusion and exclusion criteria for study participants:

Inclusion Criteria

Age ≥18 years of age
Confirmed diagnosis of IBD (CD, UC or indeterminate colitis)
Willing to provide consent for participation
Managed at an outpatient clinic either the Yale New Haven Hospital system or the University of Texas at Austin Hospital system.

Exlusion Criteria

Patients <18
No confirmed diagnosis of IBD
Not planning to continue care at either study site (i.e. presenting for a consultation only)
Unwilling to provide signed consent

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied.

Inflammatory Bowel Disease

Intervention/Treatment

OTHER : NO INTERVENTION

Sponsor

University of Texas at Austin